NASDAQ:RNVA - Nasdaq -
0.59
-0.09 (-13.24%)
The current stock price of RNVA is 0.59 null. In the past month the price decreased by -80.33%. In the past year, price decreased by -99.13%.
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company's solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.
Rennova Health Inc.
400 S. Australian Avenue 8th Floor
West Palm Beach FL 33401
CEO: Seamus Lagan
Phone: 561-855-1626
The current stock price of RNVA is 0.59 null. The price decreased by -13.24% in the last trading session.
The exchange symbol of Rennova Health Inc. is RNVA and it is listed on the Nasdaq exchange.
RNVA stock is listed on the Nasdaq exchange.
Rennova Health Inc. (RNVA) has a market capitalization of 802.40K null. This makes RNVA a Nano Cap stock.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RNVA does not pay a dividend.
Rennova Health Inc. (RNVA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-184.07).
ChartMill assigns a fundamental rating of 2 / 10 to RNVA. RNVA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months RNVA reported a non-GAAP Earnings per Share(EPS) of -184.07180000000002. The EPS decreased by -89.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -2882.34% | ||
ROA | -1457.46% | ||
ROE | 473.21% | ||
Debt/Equity | -0.17 |